Bigelow Amee M, Kapcar Catherine, Lloyd Eric, Wright Lydia K, Blais Benjamin A, Voss Jordan, Walczak Ashley B, Deitemeyer Matthew, Duffy Vicky, Nandi Deipanjan, McConnell Patrick I
Department of Pediatrics, The Heart Center, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
Department of Cardiothoracic Surgery and Perfusion Services, The Heart Center, Nationwide Children's Hospital, Columbus, Ohio.
Ann Thorac Surg Short Rep. 2023 Dec 27;2(2):277-281. doi: 10.1016/j.atssr.2023.12.004. eCollection 2024 Jun.
Right ventricular (RV) failure after heart transplantation (HT) is common in those with pretransplantation elevated pulmonary vascular resistance (PVR). Mechanical circulatory support has been used as a bridge to recovery, with mixed outcomes. We describe a patient with failed single-ventricle palliation in whom severe RV failure developed after HT. We review the current literature and outline our post-HT strategy.
An infant with trisomy 21, severely unbalanced right dominant atrioventricular septal defect, and hypoplastic aortic arch was palliated with a hybrid procedure. At 6 months of age, cardiac catheterization measured PVR index of 5.47 Wood units × m on maximal medical therapy. The patient was deemed unsuitable for second-stage palliation and underwent HT at 18 months of age. Despite preemptive medical therapies, acute RV failure developed, necessitating extracorporeal membrane oxygenation. He was quickly converted to main pulmonary artery to left atrial cannulation. Unloaded RV function normalized; he was weaned from support and discharged home 5 weeks after HT.
Failure of medical therapy in RV failure after HT requires escalation to mechanical circulatory support. We review the literature on RV failure and support after HT. We also describe a novel cannulation strategy to provide a reliable way to directly reduce RV afterload, to allow physiologic training of the right ventricle to a higher PVR, and to maintain normal left ventricular coupling and loading.
In pediatric patients with elevated PVR undergoing HT, advanced therapies can be used effectively to treat acute RV failure. Unique cannulation strategies may play a role in improving survival of similar patients.
心脏移植(HT)后右心室(RV)衰竭在移植前肺血管阻力(PVR)升高的患者中很常见。机械循环支持已被用作恢复的桥梁,但结果不一。我们描述了一名单心室姑息治疗失败的患者,其在HT后发生了严重的RV衰竭。我们回顾了当前的文献并概述了我们的HT后策略。
一名患有21三体综合征、严重不平衡的右优势型房室间隔缺损和主动脉弓发育不全的婴儿接受了混合手术进行姑息治疗。在6个月大时,心脏导管检查测得在最大药物治疗下PVR指数为5.47伍德单位×米。该患者被认为不适合进行二期姑息治疗,并在18个月大时接受了HT。尽管采取了预防性药物治疗,但仍发生了急性RV衰竭,需要进行体外膜肺氧合。他很快被转换为主肺动脉至左心房插管。卸载后RV功能恢复正常;他在HT后5周脱离支持并出院回家。
HT后RV衰竭的药物治疗失败需要升级为机械循环支持。我们回顾了关于HT后RV衰竭和支持的文献。我们还描述了一种新颖的插管策略,以提供一种可靠的方法来直接降低RV后负荷,使右心室能够适应更高的PVR进行生理训练,并维持正常的左心室耦合和负荷。
在接受HT的PVR升高的儿科患者中,先进的治疗方法可有效治疗急性RV衰竭。独特的插管策略可能在提高类似患者的生存率方面发挥作用。